Medtronic executives Nnamdi Njoku and Charlie Covert discuss Medtronic’s latest initiatives in Neuromodu...
SmartTRAK identifies emerging technologies at the most recent SNIS and ESMINT meetings that have the pot...
Growth in the SCS and DBS segments remained soft in Q322 as companies continue to wrestle with macro-env...
SNIS President Michael Chen, MD discusses advancing stroke research and innovation in an interview with ...
Georg Schauer, PhD, President of Acandis Inc., discusses the Company, its novel devices and targeting th...
Adam Hattan, VP of Marketing for Route 92 Medical, discusses the Company, its novel system for mechanica...
Wallaby Medical CEO and founder Michael Alper discusses the Company’s recent acquisition of phenox GmBH ...
Rafael Carbunaru, PhD, Boston Scientific’s VP of R&D, discusses DBS therapy and STIMVIEW XT, the Com...
Q122 SCS Market revenues were up in the low-single digit YoY, but pandemic-related issues made it a bump...
Ryan Lakin, Abbott DVP of R&D, discusses opportunities in neuromodulation in an interview with Smart...